30 studies found for:    "Congenital porphyria"
Show Display Options
Rank Status Study
1 Recruiting Longitudinal Study of the Porphyrias
Conditions: Acute Porphyrias;   Cutaneous Porphyrias
Intervention:
2 Recruiting Clinical Diagnosis of Acute Porphyria
Conditions: Hereditary Coproporphyria (HCP);   Acute Intermittent Porphyria (AIP);   Variegate Porphyria (VP)
Intervention:
3 Recruiting Controlled Trial of Panhematin in Treatment of Acute Attacks of Porphyria
Condition: Acute Porphyrias
Interventions: Biological: Panhematin;   Other: Placebo
4 Completed Observational Study of Acute Intermittent Porphyria Patients
Condition: Acute Intermittent Porphyria
Intervention:
5 Active, not recruiting Phase I Gene Therapy Clinical Trial Using the Vector rAAV2/5-PBGD for the Treatment of Acute Intermittent Porphyria
Condition: Acute Intermittent Porphyria
Interventions: Genetic: rAAV2/5-PBGD vector dosage 1;   Genetic: rAAV2/5-PBGD vector dosage 2;   Genetic: rAAV2/5-PBGD vector dosage 3;   Genetic: rAAV2/5-PBGD vector dosage 4
6 Not yet recruiting Dental Health, Diet, Inflammation and Biomarkers in Patients With Acute Intermittent Porphyria(AIP)
Condition: Acute Intermittent Porphyria
Intervention:
7 Completed Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute Porphyrias
Condition: Porphyria
Interventions: Drug: heme arginate;   Drug: tin mesoporphyrin
8 Completed
Has Results
Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda
Condition: Porphyria Cutanea Tarda
Intervention: Drug: Deferasirox
9 Completed Risk Factors of Porphyria Cutanea Tarda (PCT)
Condition: Porphyria Cutanea Tarda
Intervention:
10 Recruiting Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda
Condition: Porphyria Cutanea Tarda
Interventions: Drug: Hydroxychloroquine;   Procedure: Phlebotomy
11 Completed Phase I/II Study of Heme Arginate and Tin Mesoporphyrin for Acute Porphyria
Condition: Porphyria
Interventions: Drug: heme arginate;   Drug: tin mesoporphyrin
12 Unknown  Safety and Efficacy of Oral Deferasirox in Patients With Porphyria Cutanea Tarda
Condition: Porphyria Cutanea Tarda
Intervention: Drug: Exjade
13 Completed Study of the Pathogenesis of Porphyria Cutanea Tarda
Condition: Porphyria Cutanea Tarda
Intervention:
14 Completed Study of Nutritional Factors in Porphyria
Condition: Porphyria
Intervention:
15 Completed Phase I Study of Heme Arginate With or Without Tin Mesoporphyrin in Patients With Acute Attacks of Porphyria
Condition: Porphyria
Interventions: Drug: heme arginate;   Drug: tin mesoporphyrin
16 Completed Phase I Study of Tin Mesoporphyrin in Patients on Long Term Heme Therapy for Prevention of Acute Attacks of Porphyria
Condition: Porphyria
Interventions: Drug: heme arginate;   Drug: tin mesoporphyrin
17 Unknown  Studies in Porphyria I: Characterization of Enzyme Defects
Condition: Porphyria
Intervention:
18 Completed Studies in Porphyria IV: Gonadotropin-Releasing Hormone (GnRH) Analogues for Prevention of Cyclic Attacks
Condition: Porphyria
Intervention: Drug: luteinizing hormone-releasing factor
19 Completed Porphozym in the Treatment of Acute Attacks in AIP
Condition: Acute Intermittent Porphyria
Intervention: Drug: recombinant human porphobilinogen deaminase (Porphozym)
20 Completed Sorbent Therapy of the Cutaneous Porphyrias
Condition: Erythropoietic Protoporphyria
Intervention: Drug: Colestipol

Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results
Indicates status has not been verified in more than two years